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Abstract
The emergence of biogenic nanomaterials as novel antimicrobials introduces 
a new paradigm in human health care. Based on the recent reports of the World 
Health Organization, infectious diseases pose one of the greatest health challenges. 
Increased multi-drug resistance prevalence among human pathogens, due to the 
inefficiency of commercially available antimicrobial drugs in the market is a great 
threat to humans. The poor solubility, stability and side effects of the antibacterial 
therapy prompted the researchers to explore new innovative strategies for developing 
new antimicrobials. Recently, biogenic nanoparticles have proven their effectiveness 
against multidrug-resistant (MDR) pathogens as an alternative to conventional anti-
biotics. Biogenic nanoparticles such as silver nanoparticles (AgNPs) and Zinc Oxide 
nanoparticles (ZnONPs) are easy to produce, biocompatible, provide enhanced 
uptake and are eco-friendly. Moreover, the capping of the biogenic nanocrystals 
provides an active surface for interaction with biological components, facilitated by 
free active surface functional groups to enhance their efficacy and delivery. Inorganic 
nanocrystals (AgNPs and ZnONPs) are effective both as nano-bactericides and as 
nanocarriers against sensitive and MDR) pathogens. The present chapter focuses on 
the utilization of the recent nanosystems to combat drug resistance in human patho-
gens. Nanomedicine represents a new generation of potiential antimicrobial candi-
dates capable of combating the drug resistance in various pathogenic organisms.
Keywords: Antimicrobials, MDR, AgNPs, ZnONPs, nanocrystals, biogenic 
nanoparticles
1. Introduction
Nanotechnology is regarded as a new discipline that has a significant influence 
on human life in several respects with various applications [1]. Current nanosci-
ence research is based on nanoparticle synthesis. Metal nanoparticles are used for a 
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wide range of applications including biosensors, organic marking, cancer therapy, 
textiles, household and industrial applications etc. Silver nanoparticles AgNPs are 
mostly used in wound dressings, care of the eye, oral hygiene, biomaterials of bone 
substitutes, antimicrobial and anti-inflammatory drugs as well as in the coating 
of catheter products as anti-inflammatory and antimicrobial agents [2]. Silver is a 
stable and non-hazardous antibiotic agent used for centuries [3]. Most antimicrobi-
als have many disadvantages including low stability, environmental toxicity and the 
lack of specificity towards the target microorganisms [4]. Few other antimicrobials 
are extremely irritating and expensive to develop [5].
Silver has the unusual property of binding cellular components that are far 
larger than nuclear acids [6]. AgNPs may be synthesized employing physical, 
chemical and biological processes. The majority of the physical and chemical 
processes of synthesizing nanoparticles have many disadvantages such as low 
yield, strong reducing agents, energy-intensive mechanisms, uneven particle size 
and aggregate instability, hazardous waste production, difficulty to scale up and 
expensive organo-metallic precursors are required [7]. Biological approaches for the 
synthesis of nanoparticles are regarded as more stable and efficient [8]. For several 
nanoparticles like gold, silver, platinum and palladium, titanium dioxide, magnetite 
and cadmium sulphide, the most possible bio-factories are bacteria. Bacteria-
mediated AgNPs synthesis is preferred in comparison with other techniques.
Furthermore, bacteria mediated AgNPs are simpler to grow and environment 
friendly. Both intracellular (biomass) as well as extracellular (cell extracts) syn-
thesis of silver nanoparticles can be performed. Intracellular approaches include 
the release of synthesized nanoparticles through ultrasonication and additional 
reactions with specific detergents. It is therefore essential that the AgNPs are 
synthesized with extracellular methods because of their easy downstream process-
ing that supports large-scale development [7, 9, 10]. There is now a prevalence of 
multiple tolerance to antibiotics by various clinical infections and pathogens of the 
urinary tract, caused by excess antibiotics and by an accumulation of antibiotics in 
the system. This kind of resistance is exhibited by Staphylococcus sp., Streptococcus 
sp., Klebsiella sp., Enterococcus sp., Proteus sp., Pseudomonas sp. and E. coli due to 
their biofilm-forming potentials [11]. The use of antimicrobial silver nanoparticles 
will eliminate the multiple-drug resistance, which is a suitable option for antibiotics 
[12]. Biofilm formation has been regarded as the global barrier in avoiding catheter-
related infections in the field of medicine [13]. The conversion of nanoparticles into 
therapeutic agents, however, involves a detailed knowledge of the physicochemical 
particularities, results in vitro and in vivo, biodistribution, pharmacokinetics and 
pharmacodynamics, apart from the suitable methods of their synthesis [14].
2. Synthesis of nanoparticles
In broader terms, nanoparticles can be synthesized either by (i) Top- down 
approach, or (ii) Bottom- up approach [15]. Based on the reaction conditions and 
operation, these two classes can be further categorized as physical, chemical and 
biological methods [15].
i. Top- down approach
 In this method, larger molecules are broken down into smaller units 
which are then transformed into suitable nanoparticles [15] According to 
a study, the synthesis of the spherical magnetite nanoparticles that uses 
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natural iron oxide is performed through top- down method which pro-
duces particle sizes ranging from 20 nm to 50 nm [15].
ii. Bottom- up approach
 This method works in reverse to the top- down approach as nanoparti-
clessynthesised using this approach are formed from smaller and relatively 
simpler substances that form clusters and are subsequently converted into 
desired nanoparticles. This technique is also known as building up approach. 
Sedimentation and reduction technique fall under this category which 
include sol gel, green synthesis, spinning and biochemical synthesis [15].
3. Green synthesis of nanoparticles
Green synthesis of nanoparticles refers to the synthesis of nanoparticles through 
biological routes such as those with the help of microorganisms, enzymes, fungus 
plants or using various plant products [16, 17] Conventional physical or chemical 
methods of nanoparticle synthesis often produce byproducts that are hazardous to 
the environment which is one of the key reasons to opt for a more suitable alterna-
tive, that is, the green synthesis or green technology [16]. Other aspects by which 
green synthesis is more superior than the physical and chemical methods are that 
they are cost efficient and consume less energy [16].
Bottom- up approach is employed in biological- based synthesis of nanoparticles 
that requires the use of stabilizing and reducing agents [16]. The process of biologi-
cally synthesizing nanoparticles is basically divided into three steps: (i) the choice 
of a suitable solvent medium used, (ii) the choice of a suitable reducing agent that 
is eco- friendly and environmentally benign, and (iii) the choice of a non- toxic 
capping agent that can stabilize the synthesized nanoparticles [16].
Prokaryotes as well as eukaryotes are used in the green synthesis of metallic 
nanoparticles such as silver, gold, platinum, iron, and metal oxides such as zinc 
oxide and titanium oxide [17].
3.1 Biological components for green synthesis
Bacteria: Prokarytic bacteria and actinomycetes are widely used in the synthesis 
of metal and metal oxide nanoparticles as they have the potential to reduce metal 
ions and therefore, are suitable candidates for the preparation of nanoparticles [18] 
. The fact that it is relatively easier to manipulate bacteria is a key point in employ-
ing them in nanoparticle synthesis [18].
Fungi: Another popular choice for the biological synthesis of metal and metal 
oxide nanoparticles is fungi as they behave as better biological agents because they 
have diverse intracellular enzymes [18]. It is also reported that fungi can compara-
tively synthesize more amounts of nanoparticles than bacteria which could also be 
because of the fact that fungi have various enzymes/proteins/reducing components 
on the surface of their cells [18].
Yeast: Saccharomyces cerevisiae has found to be quite effectively employed in the 
synthesis of silver and gold nanoparticles as reported in numerous studies [18].
Plants: The most simple, efficient, cost effective and feasible method of bio-
synthesis of metal and metal oxide nanoparticles is using plants and plant extracts 
as biological agents. Biomolecules such as carbohydrates, proteins and coenzymes 
extracted from plants are employed to reduce metal salt into nanoparticles [18].
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4. Applications of nanoparticles as antimicrobial agents
Nanoparticles have an antimicrobial activity that is capable of overcoming 
typical resistant mechanisms, including inactivation of the enzymes, reduction 
of cell permeabilities, modification of target sites/enzymes, and increasing 
efflux by excessive expression of efflux pumps to escape antimicrobial activity 
[19, 20]. In addition, NPs combined with antibiotics have a synergistic impact 
on bacteria, prevent biofilm formation and are used in combating multidrug-
resistant organisms [20, 21]. Many features of the nanoparticles provide alterna-
tives to conventional antibiotics. First, with the high volume-surface ratio of 
nanoparticles, the interaction area with the target species is increased. NP can 
function as nanoscale molecules that communicate with bacterial cells, regulate 
penetration of cell membranes and interfere with molecular pathways [22–24]. 
Secondly, nanoparticles may enhance the inhibitory effects of antibiotics. Saha 
et al. [25] reported that gold nanoparticles conjugated with ampicillin, strep-
tomycin, or kanamycin could lower the minimum inhibitory concentrations 
(MICs) of the antibiotic counterparts against both gram-negative and gram-pos-
itive bacteria. Gupta et al. [26] have shown a synergistic impact on multi-drug-
resistant Escherichia coli infections through functionalized gold nanoparticles 
and fluoroquinolone-based antibiotics.
The complexity of the physicochemical properties, including the scale, form, 
chemical changes, solvent and environmental factors may influence the anti-
bacterial properties and interfere with the bacteria during the preparation of 
nanoparticles [27]. Finally, antibiotic and nanoparticle combinations have diverse 
antimicrobial pathways for overcoming antibiotic resistance [28]. Thus, nanopar-
ticles are regarded as next-generation antibiotics.
Nanoparticles, primarily metallic, have proved effective against gram-positive 
and gram-negative bacteria in both in vitro and in vivo studies [29]. Even though 
the antimicrobial mechanisms that are based on the size, shape, zeta-potential, 
ligands, and material used are not fully understood [28–30] some of the currently 
accepted mechanisms include (1) disruption of membrane potential and integrity 
through direct contact with bacteria; (2) activation of the host immune responses; 
(3) inhibition of biofilm formation; (4) generation of reactive oxygen species 
(ROS); and (5) induction of intracellular effects to inhibit RNA and protein synthe-
sis [21, 27]. Nanoparticle coatings on implantable devices, urinary catheters, wound 
dressings, bone cement, or dental implants/materials can function as nanoparticle-
based antibiotic delivery systems [31, 32]. Furthermore, nanoparticles can be used 
as vectors to transfer and deliver higher doses of drugs to infected sites [21]. Thus, 
the combination of NPs and antimicrobial agents may be beneficial in fighting the 
ongoing crisis of antimicrobial resistance [20]. The combination of nanoparticles 
and antimicrobials could thus help to combat the current anti-microbial resistance 
crisis [20].
Nanoparticles with antimicrobial activity that combat E. faecium, S. aureus, K. 
pneumoniae, A. baumannii, P. aeruginosa, and Enterobacter species [24, 27, 33, 34] 
include the nanoparticles containing silver (Ag), gold (Au), zinc (Zn), copper (Cu), 
Titanium (Ti), magnesium (Mg), nickel (Ni), cerium (Ce), selenium (Se), alu-
minum (Al), cadmium (Cd), yttrium (Y), palladium (Pd), or superparamagnetic 
iron [24]. It has been reported that among various metallic nanoparticles and their 
oxides, silver or its ionic form is most toxic to bacteria [35]. Silver nanoparticles 
(AgNPs) find numerous uses as they possess several mechanisms of antibacterial 
activity [36], high biocompatibility, and functionalized potential and are easily 
detectable [37]. Even though AgNPs are difficult to functionalize with biomolecules 
and antibiotics, Ag–gold (Au) alloys provide an alternative, since they combine 
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the antimicrobial effects of Ag with the effectiveness of functionalization and the 
stability of Au in the form of bimetallic NPs [20]. Furthermore, Ag–Au NPs func-
tionalized with tetracycline have been shown to have a synergetic effect, which is 
attributed to the generation of ROS [38].
Antibiotic resistance is often associated with biofilm formation and an active 
quorum sensing machinery within a bacterial cell. Biofilm plays a crucial role 
by evading the action of antibiotics that hinder their entry in the cell membrane 
surface as a result rapid dissemination of resistance may occur. Almost all bacteria 
posses biofilm and it may remain in an inert state by modulating the epigenetic 
changes within its genome allowing them to develop adaptive resistance as a result. 
Exopolysaccharide capsular fractions, extracellular polymeric substances (EPS), 
also provide structural integrity that works as a barrier, restrict the antibiotic 
action by modulating the cellular integrity, further promote antimicrobial resis-
tance. Several evidences have shown the capability of nanoparticle to disrupt the 
cell membrane, hinder biofilm formation and dispute the active quorum-sensing 
systems. The design of biologically active nanoparticle has to be made in such a way 
that it must circumvent the barrier function to elicit their activity. The most pre-
dominant and promising strategy could be to interfere with the cellular signaling 
mediated by quorum sensing molecules such as Acyl homoserine lactone (AHLs) 
for Gram-negative bacteria and peptides of Gram-positive bacteria. (Figure 1).
The mechanism of the nanoparticle often dealt with the synthesis of 
N-acetylated homoserine lactonase proteins (AiiA) capable of modulating signals 
by preventing the stimuli from reaching its cognate receptor site, as a result, the 
intracellular signaling affects the communication. The activity of quorum quench-
ing could be enhanced by coupling the drug moieties into a nanoformulation. 
Enormous alternatives are available, capable enough to elicit its activity by employ-
ing dendrimers, chitosan and liposome coating to give effective drug delivery. 
Siddhardha et al. [39], have recently evaluated the anti-biofilm property of the 
chrysin-loaded chitosan nanoparticles and their role in combating infections caused 
by S.aureus. Chrysin, a plant flavone constituent of Orocylumineicum vent is well-
established for its biological properties. However, its therapeutic attributes have 
Figure 1. 
Mechanism of antimicrobial activity by nanoparticles.
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not been fully deciphered due to its poor solubility and less bioavailability. In their 
study, chrysin has been encapsulated into chitosan derived nanoparticles using TPP 
as a linker.
Nanoparticles were further characterized and assessed for their ability as an 
anti-biofilm compound against Staphylococcus aureus. In sub-Minimum Inhibitory 
Concentration, (MICs) these nanoparticles exhibited increased anti-biofilm efficacy 
against S. aureus as compared to its counterparts, chrysin and chitosan, remarkably 
reduced in the cell surface hydrophobicity index and exopolysaccharide (EPS) pro-
duction indicated by the inhibitory effect of nanoparticles on the primary stages of 
biofilm formation. However, growth curve analysis further showed that at a sub-MIC 
point nanoparticles did not exert any bactericidal effect against S. aureus. During 
the last few years, various nano-mediated delivery systems such as poly(lactic-co-
glycolic acid) (PLGA), fusogenic liposome molecules, solid lipid nanoparticles, 
also known as SLNs, are physiological lipids dispersed in aqueous surfactant and 
lipid-polymer hybrid have proven to be promising vehicles to act as a nanocarrier. 
Commercially available Protein, and lipid conjugated polymeric substance viz. 
Intron A and AmBiosome have become the most predominant nano platform to 
evaluate their efficacy in terms of countering the biofilm formation within patho-
genic bacteria. In one of the recent studies, sodium lauryl sulfate (SLSs) have been 
shown to act as anti quorum sensing agents (Quorum quencher) by downregulating 
the pyocyanin production in P. aeruginosa strain.
5. Silver nanoparticles and their antibacterial efficacy
Silver nanoparticles have been identified as an excellent antibacterial agent 
with potential medical applications. Green nanoparticle synthesis has emerged as 
a viable alternative to overcome the limitations of traditional methods of nanopar-
ticle synthesis [40]. Green synthesis of silver nanoparticles (AgNPs) employs plant 
constituents such as sugars, fats, flavonoids, alkaloids, polyphenols have become an 
alternative to the rational chemical formulation. To date, green synthesis of AgNPs 
is carried out by using fruit extract of Emblica officinalis, leaves extract of Citrus 
limon, Azadirachta indica, Coffea Arabica, Acalypha indica, Camellia sinensis, a root 
extract of Phoenix dactylifera, Morinda citrifolia, inflorescence extract of Mangifera 
indica etc. [41]. Phytochemicals exhibit various antimicrobial activities and they act 
as reducing or stabilizing agents in plants and the co-occurrence of these natural 
compounds shape the biogenic AgNPs morphology.
Paradoxically Mechanism of action of AgNPs for eliciting antibacterial efficacy 
is a controversial topic. Several research papers have shared certain assumptions 
such as Ag ions get released by the AgNPs and submerged around the cell surface 
affecting the penetration barrier of the cell wall or cell surface by dismantling the 
cellular permeability. It has been reported that AgNPs can affect DNA replication 
while interacting with thiol moieties of protein molecule initiate protein deactiva-
tion with the concomitant liberation of reactive oxygen species (ROS) [42].
Other hypotheses suggest that the receptor musking capabilities of AgNPs due 
to their size which might restrict the biofilm formation in E.coli and S.aureus by 
disputing the quorum sensing machinery. The dissolution status of AgNPs strongly 
affects their antibacterial efficacy depends on synthetic and intrinsic characteristics 
of surrounding media. The coexistence of particle size and morphology on the 
liberation of Ag + described, by the Ostwald–Freundlich equation. The presence 
of smaller AgNPs with quasi-spherical shape are more prone to Ag + release, due 
to their greater surface ratio. This quality further explains the lower silver content 
of aggregated nanoparticles, which is relative to isolated nanoparticles. Certain 
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capping agents are used to modulate the AgNPs surface, which in turn, may cause 
their dissolution behavior. Sometimes, the surrounding media itself can influence 
the release of Ag + ions. The co-occurrence of inorganic or organic components 
in a growth medium can affect the solvation potential of silver nanoparticles by 
augmenting with nascent AgNPs or coupling with silver ions. Studies have also 
shown that AgNPs release Ag + faster in acidic condition than they do in neutral 
solution [43].
Certain Gram-negative bacteria are more susceptible to AgNPs because of their 
hallmark cellular architecture, which is the presence of an outer membrane coating 
over the polymeric peptidoglycan layer. On the other hand, the cell wall of gram-
negative bacteria is much narrower than that of gram-positive bacteria, hence, the 
thick cell wall might reduce the penetration of NPs into cells. Moreover, the anti-
bacterial effects of AgNPs on gram-negative and gram-positive cell emphasize that 
uptake of AgNPs is crucial to elicit its antibacterial effect.
Silver nanoparticles, smaller than 10 nm can directly alter cell permeability, 
enter bacterial cells and cause cell damage by employing the abovementioned 
strategies. Most of the noxious biofilm formers, rapidly develop exopolymeric sub-
stances which protect bacteria from both Ag + and NPs activity by hindering their 
transport. Researchers have observed that 100% reduction or mortality of bacteria 
did not occur in the biofilm state, whereas, AgNPs with the same concentration, 
enabled their effect by killing all planktonic cells. However, the polymeric biofilm 
hinders the use AgNPs, due to its complicated cellular architecture. Diffusion coef-
ficients of AgNPs are generally related to size, shape and physicochemical charac-
teristics, which governs their mobility and bioavailability in biofilm structure. The 
diffusion coefficient decreases with increasing molar mass make it harder for larger 
AgNPs to counter biofilm formation. Inter and Intracellular transport through 
bacterial biofilm can be impacted for particles >50 nm. Chemical constituents of 
NPs can also arouse adsorption augmentation of AgNPs in the biofilm, by interfer-
ing with their diffusion profile. Lastly, electrostatic intricacy among bacteria and 
AgNPs could influence charged nanoparticles’ penetration through biofilm [44].
Silver is being considered to be a potent antimicrobial agent. Silver nanopar-
ticles (AgNPs) are the most promising inorganic NPs employed to treat a variety 
of bacterial infections. Synthesis of AgNPs could be achieved by green syntheses 
such as using plant or microbial extracts. AgNPs mediated cell death, causing cell 
wall disruption has become one of the most striking opportunities for the antimi-
crobial researcher to evaluate its efficacy in vitro. AgNPs are capable of producing 
their activity inactivating the respiratory chain followed by ROS production with 
a process of oxidation of the bacterial cellular constituents. The cell permeability 
increases upon treating with AgNPs, cause depolarization of the cell wall. AgNPs 
have been found to show synergized effect with different antibiotics that resulted 
in better efficacy. Lara et al. [45] have demonstrated the efficacy of AgNPs 
against multidrug-resistant nosocomial pathogenic bacteria such as P.aeruginosa, 
ampicillin-resistant E.coli O15:H7 and MDR Streptococci strain. It has been reported 
that Ag-bearing nanocrystals are sensitive against a variety of Gram-positive and 
Gram-negative bacteria such as Vancomycin-resistant Enterococci, S. mearcesens, 
counter the biofilm formation in MTP assays.
Antimicrobial peptides (AMPs) prove to be one of the key elements for the 
defense strategy against various high-density bacterial infections. Unfortunately, 
AMPs are sparingly soluble and have possess poor enzymatic stability, often get 
churned into pieces before they cross the biological barrier due to their low perme-
ability. Immobilization of AMPs onto NPs can be an exciting way for drug delivery. 
Polymyxin B is the most used AMP, as it has a good antibacterial activity, it modu-
lates the LPS in the outer membrane present within Gram-negative cells. It has been 
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demonstrated recently that AgNPs coupled with polymyxin-B removed endotoxin 
contamination from the surgical solutions and downregulated the biofilm forma-
tion on the blades used for surgical procedures.
6. Zinc oxide nanoparticles and their antibacterial efficacy
Zinc oxide nanoparticles are utilized in food as additives, supplements, con-
tainers, and packaging; in the energy sector as fuels and catalysts; in consumer 
electronics, semiconductors, and air filters; in biomedical engineering; and in 
drinking water.
Plant constituents such as Cassia tora, Calotropis gigantean, Hibiscus sp, Corymbia 
citriodora etc. have been used for green synthesis of ZnNPs [46, 47]. These plants 
for example, Catharanthus roseus produce secondary metabolites, containing more 
than 200 terpenoid based indole alkaloids, notable for their antimicrobial and 
anticancer activity [48].
Recently, the antibacterial efficacy of Zn NPs was assessed for Staphylococcus 
aureus MTCC 9760, Pseudmonas aeruginosa MTCC 424, Streptococcus pyogenes MTCC 
1926, Escherichia coli MTCC 40, Bacillus cereus MTCC 430 and Proteus mirabilis 
MTCC 3310. The green newly synthesized Zn NPs exhibited promising antibacte-
rial activity against both Gram-positive and Gram-negative bacteria. These results 
elucidated a rapid, cost-effective, environment friendly and convenient method for 
ZnO NPs synthesis, which could be used as a potential antimicrobial agent against 
drug-resistant microbes [49].
Zinc nanoparticles minimize the use of toxic substances in NPs fabrication and 
modulate the antibacterial efficacy and biomedical applications. Several studies 
have reported the efficacy of ZnO NPs against various pathogenic bacteria. It has 
been observed that the shape and size of ZnO NPs dependent on several physico-
chemical characteristics such as reaction kinetics, annealing temperature and pH. 
ZnONPs exhibit a strong antimicrobial efficacy for E. coli and S. aureus without UV 
illumination at NP concentration of 0.025 mg mL−1 after 8 h of incubation [50].
Green synthesis of Zn NPs could be initiated by rapid mixing of the aqueous 
solution of 0.01 M zinc acetate dehydrate with above mentioned any of the leaf 
extracts. This process is further followed by constant stirring till the appearance of 
white suspension. The pH needs to be adjusted till the ZnO NPs precipitate is com-
pletely dissolved. Finally, the spectra exhibites an absorption band with a resolution 
of 1.0 nm between 350 and 500 nm, which confirms the formation of ZnO NPs. 
Physicochemical parameters regulate the green synthesis of inorganic metal NPs. 
Hence, several physicochemical parameters are optimized such as pH, temperature; 
reaction time and concentration of the metal ions [51].
Zinc oxide NPs are characterized for their bactericidal activity by affecting 
planktonic cell growth and their proliferation. Like AgNPs the mechanism is to 
produce ROS with an adjunct to its Zn2+ release in a liquid medium, which hinders 
the enzymatic activity and normal physiological process within a healthy bacterial 
cell. The stability of these oxides is achieved by their high density, high melting 
point, high thermal conductance and conductivity. Besides ZnO, rare-earth NPs 
have become one of the alternative treatment choices and their oxide forms differ 
in chemistry from the main group elements as well as transition metals because 
the 4f orbitals of these elements are buried deep within the atom and the 4d and 
5p electrons shield the 4f orbitals from the atom’s environment and thus owing to 
the unique characteristics of these elements in terms of catalytic, magnetic and 
electronic properties which can be exploited by preparing nanoparticles from their 
oxide forms. Sarwar and his coworkers [52] have recently demonstrated that the 
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nanoformulation of ZnO has caused significant oxidative stress to Vibrio cholera, 
with a concominant downstream process of DNA degradation, protein leakage, 
membrane depolarization and fluidity as a result.
Moreover, ZnO NPs impregnated with antibiotics have shown better efficacy to 
act as an antimicrobial agent against almost every noxious biofilm formers under 
the group of ESKAPE pathogens viz. S. aureus, Proteus sp., Acinetobacter sp., P. 
aeruginosa, and E. coli, whereas the antibiotic alone found to be resistant towards 
them, showed a synergistic effect under these circumstances.
7. Nanoparticle based alloys
Nanoparticle alloys made by the combination of Ag and Au may.be used to 
enhance the effects of a drug. Even tough they have antimicrobial effects when used 
alone, once they are used in combination their effects get enhanced [30, 53]. It has 
been reported that AgNPs face difficulties in functionalizing with biomolecules and 
drugs, to overcome this limitation in monometallic NPs, alloy/bimetallic NPs have 
been introduced which possess improved electronic, optical and catalytic properties 
[54, 55]. AuNPs are considered to be good vectors for the delivery of pharmacologic 
compounds. The combinatorial effect of nanoparticle alloys increases efficacy- in 
biological media, gold enhances the functionalization improves the stability along 
with the antimicrobial activity of silver [56, 57]. Fakhri et al. [38] found that anti-
biotic (tetracycline) along with the bimetallic nanoparticles (Au-AgNPs.) showed a 
synergetic effect, with greater antimicrobial activity. Baker et al. [58] in their study 
have reported antimicrobial activity of bimetallic AgAuNPs against Pseudomonas 
veronii strain AS41G inhibiting Annona squamosa L. They also reported their 
synergistic effect with standard antibiotics against the bacitracin resistant strains 
of Bacillus subtilis, E. coli, and K. pneumoniae [58]. Zhao et al. [59] have signified the 
antibacterial activity of bimetallic NPs like AuPtNPs against drug resistant bacteria.
8. Synergistic effects of NPs with antibiotics
For overcoming antibiotic resistance, NPs can be customized and packaged with 
various antimicrobial agents. NPs use several mechanisms to combat bacterial resis-
tance. If NPs are used in combination with antibiotics, there is very less chance that 
bacteria can develop resistance [60, 61]. Thus, NPs in combination with antibiotics 
can be a promising strategy to overcome bacterial resistance. Additionally, NPs are 
effective antimicrobial delivery systems, and may reduce the dosage and toxicity 
of antibiotics [24]. Very low concentrations of AgNPs and antibiotics have been 
synergistically found to inhibit various pathogens such as S. aureus, P. aeruginosa, A. 
baumannii strains etc. [62–64]. Similarly, synergistic effects Ag, Au, and ZnO NPs 
along with antibiotics have been found to be effective against S. aureus, E. faecium, 
E. coli, A. baumannii, and P. aeruginosa [24]. The efficacy of antibiotics along with 
functionalized NPs may help in reversal of antimicrobial resistance and may also 
enhance the antimicrobial effects of various antibiotics [24].
9. Nanotoxicity
Although there is an immense progress in the field of nanotechnology, but the 
consequent health effects that are related to the exposure to nanoparticles remain 
largely unexplored. Researchers have started to characterize the risks associated 
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with nanoparticle exposure. [65]. Impact of NPs on beneficial bacteria in humans 
should be of high concern [66, 67]. It has been reported that NPs can cause heme-
olysis thus, may impair blood coagulation [68]. The precise mechanism of toxic 
effects of NPs is not so clear, but it has been observed that nanoparticles larger in 
size pose a greater threat on human health. In most of the invitro studies conducted 
on AgNPs, it has been observed that AgNPs are more toxic for cell lines [69, 70]. 
Deposition of AgNPs has been observed in many organs such as liver, lungs, spleen 
which has been linked to organ damage [24]. In blood and urine of burn patients 
elevated levels of Ag have been reported, this may be due to leaching from Ag 
wound dressing (Acticoat®),which is composed of Ag nanocrystals, into the blood 
stream [67, 71].
Neurotoxicity has been associated with Al2O3 NPs which interact with cel-
lular components [33]. CuONPs have been observed to induce oxidative damage. 
CuO NPs induce hepatotoxicity and nephrotoxicity through the generation of free 
radical-mediated oxidative stress [20, 72, 73]. DNA damage has been associated 
with ZnO or TiO2 NPs thus, limiting their use [24]. Hagens et al. [74] have reported 
that NPs that are administered intravenously could get accumulated in bone mar-
row, colon, lung, liver, spleen as well as lymphatic system. Inhalation of NPs has 
been associated with cytotoxicity in the lungs [75].
In various in vivo studies, it has been reported that there is lethal toxicity associ-
ated with the use of NPs [29, 76–78]. Nevertheless, the assessment of toxicity at the 
cellular level as well as mode of administration is crucial for clinical use of NPs [67].
10. Conclusion
Silver and Zinc NPs have the ability to interact with and influence the growth 
of a variety of microorganisms. Therefore, Ag and Zn NPs could be employed as a 
broad-spectrum antibiotic agents to combat bacterial infections. Plant extracts are 
used to make Ag and Zn NPs, which is cost-effective and eco-friendly. The antibac-
terial action of Ag and Zn NPs appears to be attributed to their structure, ultrasmall 
size, and increased surface area, which allows them to damage and pass the bacte-
rial membrane that is responsible for intracellular damage. It has been described 
that NPs in combination with antibiotics can be a promising strategy to overcome 
bacterial resistance. Synthesis of Ag and Zn NPs via green-synthesis methods and 
mechanisms of action against bacteria have been elucidated. We have also shed 
light on toxicity associated with the use of NPs. Ultimately, it can be conluded 
that both Ag and Zn sNP have broad-spectrum antibiotic activity against bacteria, 
making them prospective therapeutic agents for bacterial infections and multidrug-
resistant pathogens.
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